CN104721052A - Nanometer drug preparation device - Google Patents
Nanometer drug preparation device Download PDFInfo
- Publication number
- CN104721052A CN104721052A CN201510069755.1A CN201510069755A CN104721052A CN 104721052 A CN104721052 A CN 104721052A CN 201510069755 A CN201510069755 A CN 201510069755A CN 104721052 A CN104721052 A CN 104721052A
- Authority
- CN
- China
- Prior art keywords
- reactor
- nano
- voltage electric
- nano medication
- voltage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 229940079593 drug Drugs 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 230000005684 electric field Effects 0.000 claims abstract description 16
- 239000011259 mixed solution Substances 0.000 claims abstract description 15
- 239000000693 micelle Substances 0.000 claims abstract description 12
- 238000002347 injection Methods 0.000 claims abstract description 5
- 239000007924 injection Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 3
- 239000007769 metal material Substances 0.000 claims description 3
- 239000004005 microsphere Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims 1
- 229920002521 macromolecule Polymers 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 36
- 239000000523 sample Substances 0.000 abstract description 11
- 238000011068 loading method Methods 0.000 abstract description 8
- 238000005538 encapsulation Methods 0.000 abstract description 3
- 239000012488 sample solution Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 27
- 239000007788 liquid Substances 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000004530 micro-emulsion Substances 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 238000000593 microemulsion method Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- 238000007787 electrohydrodynamic spraying Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000001132 ultrasonic dispersion Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种纳米药物制备装置。由恒量进样器、直流高压电发生器、反应器、恒温电磁搅拌器、中央控制器组成;纳米药物制备原料的混合溶液由恒量进样器的毛细管顶端喷入反应器中;直流高压电发生器在正负电极之间产生直流高压电场,其产生的高压电压加载在位于反应器上下两端的正负电极上;混合溶液在高压电场的作用下,雾化成细小的液滴,并向下运动进入反应器内的溶剂中;在恒温电磁搅拌器的作用下,雾化液滴在溶剂形成纳米药物胶束固化成纳米药物颗粒。制备的纳米药物的粒径均匀,载药率与包封率较高、收率高。且通过调节直流高压电场的电压大小、恒量进样的流速、进样溶液的浓度,可以制备不同粒径大小的纳米药物。The invention discloses a nano medicine preparation device. It is composed of a constant volume injector, a DC high voltage generator, a reactor, a constant temperature electromagnetic stirrer, and a central controller; the mixed solution of nano-medicine preparation raw materials is sprayed into the reactor from the top of the capillary of the constant volume injector; the DC high voltage The electric generator generates a DC high-voltage electric field between the positive and negative electrodes, and the high-voltage generated by it is loaded on the positive and negative electrodes located at the upper and lower ends of the reactor; the mixed solution is atomized into fine droplets under the action of the high-voltage electric field, and flows Under the action of the constant temperature electromagnetic stirrer, the atomized droplets form nano drug micelles in the solvent and solidify into nano drug particles. The prepared nano drug has uniform particle size, high drug loading rate and encapsulation rate, and high yield. And by adjusting the voltage of the DC high-voltage electric field, the flow rate of the constant sample injection, and the concentration of the sample solution, nano-medicines with different particle sizes can be prepared.
Description
技术领域technical field
本发明具体涉及一种纳米药物制备装置。The invention specifically relates to a nano drug preparation device.
背景技术Background technique
目前纳米药物的制备方法有很多,既有液相反应、气相沉积等化学制备技术,也有机械粉碎等物理制备技术。常采用的纳米药物制备方法有渗析及溶剂挥发法、沉淀法、乳液法、微乳液法、脂质体法、超临界流体技术等技术。At present, there are many preparation methods for nanomedicine, including chemical preparation techniques such as liquid phase reaction and vapor deposition, and physical preparation techniques such as mechanical pulverization. The commonly used nano-medicine preparation methods include dialysis and solvent evaporation method, precipitation method, emulsion method, microemulsion method, liposome method, supercritical fluid technology and other technologies.
喷雾干燥技术是利用压缩空气将溶解有药物和壁材的乳液或溶液喷雾成小雾滴,在较高的温度下迅速干燥成粉粒,然后通过分离装置分离出药品的干燥技术。药品的形貌和粒度可以通过进风流量、进气温度、原料液浓度、泵入量和添加各种赋形剂来进行调节。喷雾干燥技术还可应用于制备多孔性载药纳米颗粒和难溶药物的微胶囊化。喷雾干燥法的缺点:①制备颗粒的粒度通常在微米级;②不适用于对温度敏感的药物;③喷雾干燥法多用于包埋油溶性药物,而对于水溶性药物,所制备颗粒具有明显的爆释效应。因而这些缺点限制了喷雾干燥技术在纳米药物领域应用。Spray drying technology is a drying technology that uses compressed air to spray the emulsion or solution dissolved with drugs and wall materials into small mist droplets, quickly dry them into powder particles at a higher temperature, and then separate the drugs through a separation device. The shape and particle size of the drug can be adjusted by the air flow rate, air temperature, raw material concentration, pumping volume and adding various excipients. Spray drying technology can also be applied to the preparation of porous drug-loaded nanoparticles and microencapsulation of insoluble drugs. Disadvantages of the spray-drying method: ①The particle size of the prepared particles is usually on the micron scale; ②It is not suitable for temperature-sensitive drugs; ③The spray-drying method is mostly used for embedding oil-soluble drugs, and for water-soluble drugs, the prepared particles have obvious Burst effect. Therefore, these shortcomings limit the application of spray drying technology in the field of nanomedicine.
高压均质法是在高压下(1.5×105Kpa以上)将药物溶液通过直径约25μm的孔隙挤出,流体在孔隙中的动压瞬间极大地增加,但在挤出孔隙后其静压迅速减小。根据伯努利方程,动压的急剧增加会导致静压的急剧减小,使水的沸点降低到室温以下。其结果是水在室温条件下发生剧烈沸腾并产生气穴现象和微爆,爆裂产生的瞬时高压使微粒破碎成更小的微粉。通过多次(10~15次)连续高压均质操作,可得到粒径尺寸在100至1000nm范围内,固体含量10%~20%的纳米混悬剂药物。The high-pressure homogenization method is to extrude the drug solution through pores with a diameter of about 25 μm under high pressure (above 1.5×10 5 Kpa). decrease. According to Bernoulli's equation, a sharp increase in dynamic pressure causes a sharp decrease in static pressure, lowering the boiling point of water below room temperature. The result is water boiling violently at room temperature and producing cavitation and micro-bursts, where the instantaneous high pressure of the burst breaks the particles into smaller micropowders. Through multiple (10-15) continuous high-pressure homogenization operations, the nano-suspension drug with a particle size in the range of 100 to 1000 nm and a solid content of 10% to 20% can be obtained.
超临界流体技术是将药物溶解在超临界液体中,液体通过微小孔径的喷嘴减压雾化时,随着超临界液体的迅速气化,随即析出固体纳米粒的一种技术。超临界流体技术具有显著的优点:①易于工业化,产品性状可调;②高扩散率,低粘度;③低界面张力,强溶解能力。该法的不足之处是:①只能应用于相对分子质量在10,000以下的聚乳酸纳米粒的制备,不适合于更大分子量的聚乳酸;②药物至少能在一种溶剂中是可溶的,且这种溶剂必须与一种非溶剂易混。但是目前新开发出来的化合物很难同时具备以上条件,因而无法采用超临界流体技术制备。Supercritical fluid technology is a technology in which drugs are dissolved in supercritical liquid, and when the liquid is decompressed and atomized through a nozzle with a small aperture, with the rapid gasification of the supercritical liquid, solid nanoparticles are precipitated immediately. Supercritical fluid technology has significant advantages: ①Ease of industrialization, adjustable product properties; ②High diffusivity, low viscosity; ③Low interfacial tension, strong solvency. The disadvantages of this method are: ① it can only be applied to the preparation of polylactic acid nanoparticles with a relative molecular mass below 10,000, and it is not suitable for polylactic acid with a larger molecular weight; ② it is possible for the drug to be in at least one solvent soluble, and the solvent must be miscible with a non-solvent. However, it is difficult for the newly developed compounds to meet the above conditions at the same time, so they cannot be prepared by supercritical fluid technology.
渗析及溶剂挥发法是将药物或载体用油(或水)溶解,然后将所得药物或载体溶液加入到水(或油)中分散,蒸发或渗析除去有机溶剂,药物或载体在水(或油)中因为溶解度急剧降低而聚集成核。沉淀法是通过化学反应在溶液中生成颗粒物沉淀,通过各种反应条件的控制来控制沉淀粒径的长大,从而制备纳米药物。The dialysis and solvent evaporation method is to dissolve the drug or carrier in oil (or water), then add the obtained drug or carrier solution into water (or oil) to disperse, evaporate or dialysis to remove the organic solvent, and the drug or carrier in water (or oil) ) aggregates and nucleates due to a sharp decrease in solubility. The precipitation method is to generate particle precipitation in the solution through chemical reaction, and control the growth of the particle size of the precipitation through the control of various reaction conditions, so as to prepare nano-medicine.
乳液法是在乳液中制备纳米药物的方法。一般利用表面活性剂的分散作用,加上外力的剪切作用形成小液滴,在液滴表面或内部发生反应成核,得到小颗粒。也有利用两性高分子聚合物在乳液中自组装成核的。具体方法有乳液聚合法、乳液自组装成核法、乳化交联法及膜乳化法等。Emulsion method is a method for preparing nano-medicine in emulsion. Generally, the dispersing effect of the surfactant and the shearing effect of the external force are used to form small droplets, and the reaction nucleation occurs on the surface or inside of the droplets to obtain small particles. There are also self-assembled nuclei using amphoteric polymers in emulsions. The specific methods include emulsion polymerization, emulsion self-assembly nucleation method, emulsification cross-linking method and membrane emulsification method.
微乳液和乳液虽然都是油相和水相形成的分散体系,但两者之间存在根本性差异。微乳液是热力学稳定的可以自发形成或经轻微外力作用即可形成的透明或半透明分散体系。而乳液却是不稳定的,静置一段时间就会分层。微乳液可以形成纳米数量级的小池,如果把各种反应限制在这个小池中进行,可以想象反应产物也是纳米的。而且,微乳液法反应条件十分温和,通过改变微乳液的配方,改变外部条件可以方便地使微乳液变相(水包油,油包水,双连续相),改变小池的形状(球状,棒状,层状等),从而得到不同纳米结构的产物。而微乳液最吸引人的地方是它可以同时增溶大量的水和大量的油,从而可以使水溶性物质和油溶性物质充分地混合,极大地提高反应效率。根据微乳液的类型可以分为正相微乳液法(O/W)和反相微乳液法(W/O)。Although both microemulsions and emulsions are dispersion systems formed by oil phase and water phase, there are fundamental differences between them. Microemulsion is a thermodynamically stable transparent or translucent dispersion system that can be formed spontaneously or by a slight external force. The emulsion is unstable, and it will separate after standing for a period of time. Microemulsions can form small pools of nanometer scale. If various reactions are limited in this small pool, it is conceivable that the reaction products are also nanometer. Moreover, the reaction conditions of the microemulsion method are very mild. By changing the formula of the microemulsion and changing the external conditions, the phase change of the microemulsion (oil-in-water, water-in-oil, bicontinuous phase) can be easily changed, and the shape of the small pool (spherical, rod, Layered, etc.), so as to obtain products with different nanostructures. The most attractive part of microemulsion is that it can solubilize a large amount of water and a large amount of oil at the same time, so that water-soluble substances and oil-soluble substances can be fully mixed, and the reaction efficiency is greatly improved. According to the type of microemulsion, it can be divided into direct phase microemulsion method (O/W) and reverse phase microemulsion method (W/O).
纳米脂质体制备方法主要有薄膜蒸发法、逆相蒸发法、薄膜超声分散法等。薄膜蒸发法..将药物和胆固醇、磷脂一起溶于有机溶剂,蒸发溶剂使药物与磷脂等成膜材料在烧瓶壁形成均匀类脂薄膜,加入冲洗液洗膜得到脂质体混悬液。逆相蒸发法是将卵磷脂、胆固醇和有机溶剂混合,在形成的有机溶液中加入溶解了药物的水溶液,形成比较稳定的W/O型乳液,然后减压蒸发除去有机溶剂,达到胶态后,加入磷酸盐缓冲溶液,水化,继续短时减压蒸发,即得淡乳黄色脂质体混悬液。薄膜超声分散法是先制备磷脂双分子膜层,再超声水化分散得脂质体。Nanoliposome preparation methods mainly include thin film evaporation method, reverse phase evaporation method, thin film ultrasonic dispersion method and so on. Thin film evaporation method. Dissolve the drug, cholesterol, and phospholipids in an organic solvent, evaporate the solvent to form a uniform lipid film on the wall of the flask with film-forming materials such as the drug and phospholipids, and then add washing solution to wash the film to obtain a liposome suspension. The reverse-phase evaporation method is to mix lecithin, cholesterol and an organic solvent, add an aqueous solution in which the drug is dissolved in the formed organic solution to form a relatively stable W/O emulsion, and then evaporate the organic solvent under reduced pressure to achieve a colloidal state. , add phosphate buffer solution, hydrate, and continue to evaporate under reduced pressure for a short time to obtain a light milky yellow liposome suspension. Thin-film ultrasonic dispersion method is to prepare phospholipid bimolecular membrane first, and then ultrasonically hydrate and disperse liposomes.
然而目前这些方法制备的纳米药物具有重复性较差、粒径不均匀、载药率与包封率较低、收率较低、工艺不稳定、难以扩大生产量的缺点。However, the nanomedicine prepared by these methods has the disadvantages of poor reproducibility, uneven particle size, low drug loading and encapsulation efficiency, low yield, unstable process, and difficulty in expanding production.
发明内容Contents of the invention
本发明目的在于提供一种纳米药物制备装置,用以大规模制备粒径均匀、稳定的各种纳米或微球颗粒药物。The purpose of the present invention is to provide a nano-medicine preparation device, which is used for large-scale preparation of various nano- or micro-spherical drug with uniform particle size and stability.
一种纳米药物制备装置,由恒量进样器、直流高压电发生器、反应器、恒温电磁搅拌器、中央控制器组成;纳米药物制备原料的混合溶液由恒量进样器的毛细管顶端喷入反应器中;所述直流高压电发生器在正负电极之间产生直流高压电场,其产生的高压电压加载在位于反应器上下两端的正负电极上;喷入反应器中的混合溶液在高压电场的作用下,雾化成细小的液滴,并向下运动进入反应器内的溶剂中;在恒温电磁搅拌器的作用下,雾化液滴在溶剂形成纳米药物胶束,进一步固化成纳米药物颗粒,并分散均匀。A nano-medicine preparation device, which is composed of a constant volume injector, a DC high-voltage generator, a reactor, a constant temperature electromagnetic stirrer, and a central controller; the mixed solution of nano-medicine preparation raw materials is sprayed from the top of the capillary of the constant volume injector In the reactor; the DC high-voltage electric generator generates a DC high-voltage electric field between the positive and negative electrodes, and the high voltage generated by it is loaded on the positive and negative electrodes at the upper and lower ends of the reactor; the mixed solution sprayed into the reactor is Under the action of a high-voltage electric field, it is atomized into fine droplets, and moves downward into the solvent in the reactor; under the action of a constant temperature electromagnetic stirrer, the atomized droplets form nano-drug micelles in the solvent, and further solidify into nano-particles. Drug particles, and dispersed evenly.
按上述方案,所述直流高压电发生器电压的大小、时间由中央控制器中直流高压电发生器分控制器进行控制与调节,并显示数据。According to the above scheme, the magnitude and time of the voltage of the DC high voltage generator are controlled and adjusted by the sub-controller of the DC high voltage generator in the central controller, and the data are displayed.
按上述方案,混合溶液的流速、进样时间由中央控制器中恒量进样器分控制器进行操作与管理,并显示数据。According to the above scheme, the flow rate and injection time of the mixed solution are operated and managed by the sub-controller of the constant sample injector in the central controller, and the data are displayed.
按上述方案,反应器内压强、温度、溶剂体积由中央控制器中反应器分控制器进行控制与调节,并显示数据。According to the above scheme, the pressure, temperature and solvent volume in the reactor are controlled and regulated by the sub-controller of the reactor in the central controller, and the data are displayed.
按上述方案,溶剂的温度、升热与降温速度、搅拌速度由中央控制器中恒温电磁搅拌器分控制器控制与调节,并显示数据。According to the above scheme, the temperature of the solvent, the speed of heating and cooling, and the stirring speed are controlled and regulated by the sub-controller of the constant temperature electromagnetic stirrer in the central controller, and the data are displayed.
上述纳米药物制备装置在高分子载体、无机非金属材料、纳米或微球药物、胶囊型药物制备中的应用。The application of the above-mentioned nano drug preparation device in the preparation of polymer carriers, inorganic non-metallic materials, nano or microsphere drugs, and capsule drugs.
将药物、高分子等载体、各种助剂等溶解在溶剂中形成一定浓度的混合溶液,混合溶液以一定的流速,通过一定孔径的毛细管顶端,喷入反应器中。在高压电压的作用下,喷入反应器中的混合溶液进行雾化成细小的液滴,并向下运动进入不同溶剂中,在一定温度、一定搅拌速度的作用下,雾化液滴在溶剂中形成纳米药物胶束,进一步固化成纳米药物颗粒,并分散均匀。Drugs, polymers and other carriers, various additives, etc. are dissolved in a solvent to form a mixed solution of a certain concentration, and the mixed solution is sprayed into the reactor at a certain flow rate through the top of a capillary with a certain aperture. Under the action of high voltage, the mixed solution sprayed into the reactor is atomized into fine droplets, and moves down into different solvents. Under the action of a certain temperature and a certain stirring speed, the atomized droplets are in the solvent Form nano-drug micelles, further solidify into nano-drug particles, and disperse evenly.
与目前传统的纳米药物制备方法相比,本发明的纳米药物制备装置可以使一定浓度的药物、高分子等载体、各种助剂等的混合溶液在高压电压的作用下,充分混合并雾化成所需要的各种细小的液滴,再进入不同溶剂中,从而形成纳米药物胶束,进一步固化成粒径大小均匀的纳米药物颗粒。Compared with the current traditional nano-medicine preparation method, the nano-medicine preparation device of the present invention can fully mix and atomize a mixed solution of a certain concentration of drugs, polymers and other carriers, various auxiliary agents, etc. under the action of high voltage. The required various tiny droplets enter different solvents to form nano-drug micelles, which are further solidified into nano-drug particles with uniform particle size.
本发明的有益效果在于:The beneficial effects of the present invention are:
(1)制备的纳米药物的粒径均匀,载药率与包封率较高、收率高。(1) The particle size of the prepared nano-medicine is uniform, the drug loading rate and encapsulation rate are high, and the yield is high.
(2)制备的纳米药物的粒径尺寸大小可控,通过调节直流高压电场的电压大小、恒量进样的流速、进样溶液的浓度,可以制备不同粒径大小的纳米药物。(2) The particle size of the prepared nano-medicine is controllable. By adjusting the voltage of the DC high-voltage electric field, the flow rate of constant sample injection, and the concentration of the sample solution, nano-medicines with different particle sizes can be prepared.
(3)制备的纳米药物的粒径尺寸的重复性好,稳定,操作简便。(3) The particle size of the prepared nano drug has good reproducibility, stability and easy operation.
附图说明Description of drawings
图1:纳米药物制备装置示意图;Figure 1: Schematic diagram of nanomedicine preparation device;
图2:实施例1纳米颗粒的TEM照片35nm;Fig. 2: TEM photograph 35nm of embodiment 1 nanoparticle;
图3:实施例1纳米颗粒的TEM照片100nm;Fig. 3: TEM photograph 100nm of embodiment 1 nanoparticle;
图4:实施例1纳米颗粒的TEM照片80nm;Fig. 4: TEM photograph 80nm of embodiment 1 nanoparticle;
1-恒量进样器;2-直流高压电发生器;3-反应器;4-恒温电磁搅拌器;5、6-正负电极;7-中央控制器;8-进料口;9-出料口;其中7-1-恒量进样器分控制器;7-2-直流高压电发生器分控制器;7-3-反应器分控制器;7-4-恒温电磁搅拌器分控制器。1-Constant sample injector; 2-DC high voltage generator; 3-Reactor; 4-Constant temperature electromagnetic stirrer; 5, 6-Positive and negative electrodes; 7-Central controller; 8-Feeding port; 9- Outlet; among them, 7-1-constant sampler sub-controller; 7-2-DC high voltage generator sub-controller; 7-3-reactor sub-controller; 7-4-constant temperature electromagnetic stirrer sub-controller controller.
具体实施方式Detailed ways
以下实施例进一步阐释本发明的技术方案,但不作为对本发明保护范围的限制。The following examples further illustrate the technical solutions of the present invention, but are not intended to limit the protection scope of the present invention.
本发明纳米药物制备装置,参照附图1所示,由恒量进样器1、直流高压电发生器2、反应器3、恒温电磁搅拌器4、中央控制器7组成;纳米药物制备原料的混合溶液由恒量进样器1的毛细管顶端喷入反应器3中;所述直流高压电发生器在正负电极之间产生直流高压电场,其产生的高压电压加载在位于反应器3上下两端的正、负电极(5、6)上;喷入反应器3中的混合溶液在高压电场的作用下,雾化成细小的液滴,并向下运动进入反应器内的溶剂中;在恒温电磁搅拌器4的作用下,雾化液滴在溶剂形成纳米药物胶束,进一步固化成纳米药物颗粒,并分散均匀。同时反应器7上下还设置有进料口8和出料口9。Nano drug preparation device of the present invention, with reference to shown in accompanying drawing 1, is made up of constant sample injector 1, DC high-voltage electric generator 2, reactor 3, constant temperature electromagnetic stirrer 4, central controller 7; Nano drug preparation raw material The mixed solution is sprayed into the reactor 3 from the top of the capillary of the constant volume injector 1; On the positive and negative electrodes (5, 6) at the end; the mixed solution sprayed into the reactor 3 is atomized into fine droplets under the action of a high-voltage electric field, and moves downward into the solvent in the reactor; Under the action of the agitator 4, the atomized liquid droplets form nano-medicine micelles in the solvent, which are further solidified into nano-medicine particles and dispersed uniformly. At the same time, the reactor 7 is also provided with a feed port 8 and a feed port 9 up and down.
其中,直流高压电发生器电压的大小、时间由中央控制器中直流高压电发生器分控制器7-2进行控制与调节,并显示数据;电压范围为0-40000V。Wherein, the magnitude and time of the DC high voltage generator voltage are controlled and adjusted by the DC high voltage generator sub-controller 7-2 in the central controller, and display data; the voltage range is 0-40000V.
混合溶液的流速、进样时间由中央控制器中恒量进样器分控制器7-1进行操作与管理,并显示数据;流速范围为0.001-5000mL/min。The flow rate and injection time of the mixed solution are operated and managed by the sub-controller 7-1 of the constant sample injector in the central controller, and the data is displayed; the flow rate range is 0.001-5000mL/min.
按上述方案,反应器内压强、温度、溶剂体积由中央控制器中反应器分控制器7-3进行控制与调节,并显示数据;反应器的进料口用计量控制阀调控;反应器的出料口由计量控制阀调控。。According to the above scheme, the pressure, temperature, and solvent volume in the reactor are controlled and regulated by the sub-controller 7-3 of the reactor in the central controller, and display data; the feed port of the reactor is regulated and controlled by a metering control valve; The discharge port is regulated by the metering control valve. .
溶剂的温度、升热与降温速度、搅拌速度由中央控制器中恒温电磁搅拌器分控制器7-4控制与调节,并显示数据;转速范围为0-10000rpm。The temperature of the solvent, the heating and cooling speed, and the stirring speed are controlled and regulated by the sub-controller 7-4 of the constant temperature electromagnetic stirrer in the central controller, and the data is displayed; the speed range is 0-10000rpm.
中央控制器设有四个独立的参数控制彩色液晶屏、触摸感应屏、手动旋钮、档位调节装置、或其他显示屏,分别为调控对应装置的控制器显示屏,用于调节、控制对应装置的各种运行参数。The central controller is equipped with four independent parameter control color LCD screens, touch-sensitive screens, manual knobs, gear adjustment devices, or other display screens, which are the controller screens for adjusting and controlling the corresponding devices, and are used to adjust and control the corresponding devices. various operating parameters.
上述纳米药物制备装置可用于高分子载体、无机非金属材料与各类药物的复合物制备纳米或微球药物、胶囊型药物等各种纳米或微球颗粒材料。其纳米颗粒的直径范围为0.1-100nm,纳米颗粒的直径范围为0.1-100nm,微球颗粒的直径范围为0.1μm-1mm。The above-mentioned nano-medicine preparation device can be used to prepare various nano- or micro-spherical particle materials such as nano- or micro-spherical drugs, capsule-type drugs, etc. from the composites of polymer carriers, inorganic non-metallic materials and various drugs. The diameter range of the nanometer particle is 0.1-100nm, the diameter range of the nanometer particle is 0.1-100nm, and the diameter range of the microsphere particle is 0.1μm-1mm.
实施例1Example 1
聚碳酸酯纳米药物的制备:Preparation of polycarbonate nanomedicine:
将10mg聚碳酸酯共聚物和1mg 5-氟尿嘧啶溶解于2mL的二甲亚砜(DMSO)中,将其置于母液瓶中,采用高压电场电雾化法制备聚合物纳米药物。所制得的纳米药物在无水乙醇中沉积,抽干溶剂后,用蒸馏水溶解分散胶束。高分子纳米颗粒尺寸采用ZetasizerNano ZS粒径仪测定。10 mg of polycarbonate copolymer and 1 mg of 5-fluorouracil were dissolved in 2 mL of dimethyl sulfoxide (DMSO), which were placed in a mother liquor bottle, and polymer nanomedicine was prepared by high-voltage electric field electrospray method. The prepared nano-medicine is deposited in absolute ethanol, and after the solvent is drained, distilled water is used to dissolve and disperse the micelles. The size of polymer nanoparticles was determined by a ZetasizerNano ZS particle size analyzer.
高压电场电雾化法制备纳米胶束的过程中,采用正交实验的方法,进一步研究了样品浓度、毛细管加载电压、流量等对胶束尺寸的影响。表1中结果显示,加大毛细管的加载电压或降低样品浓度,有利于较小粒径胶束的制备;而增大样品的输入流量,制备出的药物颗粒粒径也会变大。通过对比透析法和高压电场电雾化法两种制备纳米药物的方法,可以看出,高压电场电雾化法制备的纳米药物粒径要远小于采用透析法制备的纳米药物粒径。In the process of preparing nano micelles by high-voltage electric atomization method, the influence of sample concentration, capillary loading voltage and flow rate on the size of micelles was further studied by using the method of orthogonal experiment. The results in Table 1 show that increasing the loading voltage of the capillary or reducing the sample concentration is conducive to the preparation of micelles with smaller particle sizes; and increasing the input flow rate of the sample will also increase the particle size of the prepared drug particles. By comparing the two methods of preparing nano-medicines, dialysis and high-voltage electric field electrospraying, it can be seen that the particle size of nano-drugs prepared by high-voltage electric field electrospraying is much smaller than that prepared by dialysis.
表1Table 1
实施例2:Example 2:
将100mg含羟基的聚碳酸酯共聚物和10mg阿霉素溶解于20mL的二甲亚砜(DMSO)中,将其置于母液瓶中,采用高压电场电雾化法制备聚合物纳米药物。所制得的纳米药物在无水乙醇中沉积,抽干溶剂后,用蒸馏水溶解分散胶束。100 mg of hydroxyl-containing polycarbonate copolymer and 10 mg of doxorubicin were dissolved in 20 mL of dimethyl sulfoxide (DMSO), placed in a mother liquor bottle, and polymer nanomedicine was prepared by high-voltage electric field electrospray method. The prepared nano-medicine is deposited in absolute ethanol, and after the solvent is drained, distilled water is used to dissolve and disperse the micelles.
高分子纳米胶束形态采用Tecnai G220型透射电子显微镜和原子力显微镜测定。纳米胶束尺寸采用Zetasizer Nano ZS粒径仪测定。The morphology of polymer nanomicelle was determined by Tecnai G220 transmission electron microscope and atomic force microscope. The size of the nanomicelles was determined using a Zetasizer Nano ZS particle size analyzer.
液体电雾化的工作参数可变的有:液体种类、毛细管加载电压、液体流量、电极距离。液体的粘度、表面张力、电导率、介电常数与液体种类有关。电场强度、电容与电极距离有关。液体带电量与液体流量有关。上述参数影响液体滴直径大小。采用高压电场电雾化法制备共聚物纳米药物,主要研究了聚合物投料比、毛细管加载电压、液体流量和溶液浓度的影响。以上因素对聚合物纳米胶束的影响见表2。The variable working parameters of liquid electrospray include: liquid type, capillary loading voltage, liquid flow rate, and electrode distance. The viscosity, surface tension, conductivity, and dielectric constant of a liquid are related to the type of liquid. The electric field strength and capacitance are related to the electrode distance. Liquid charge is related to liquid flow. The above parameters affect the droplet diameter size. Copolymer nanomedicine was prepared by high-voltage electric field electrospray method, and the effects of polymer feed ratio, capillary loading voltage, liquid flow rate and solution concentration were mainly studied. The influence of the above factors on the polymer nanomicelle is shown in Table 2.
表2Table 2
从表2可以看出,降低样品浓度或加大毛细管的加载电压,有利于制备较小粒径的胶束;而加大样品的输入流量,则制备的药物颗粒粒径变大。It can be seen from Table 2 that reducing the sample concentration or increasing the loading voltage of the capillary is conducive to the preparation of micelles with smaller particle sizes; while increasing the input flow rate of the sample, the particle size of the prepared drug particles becomes larger.
参照附图1、2、3所示,从透射电子显微镜的观察结果来看,高压电场电雾化制得大小比较均一的球状纳米药物,相互之间没有粘附。Referring to Figures 1, 2, and 3, from the observation results of the transmission electron microscope, high-voltage electric field electrospraying produces spherical nano-medicines of relatively uniform size, and there is no adhesion between them.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510069755.1A CN104721052A (en) | 2015-02-10 | 2015-02-10 | Nanometer drug preparation device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510069755.1A CN104721052A (en) | 2015-02-10 | 2015-02-10 | Nanometer drug preparation device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104721052A true CN104721052A (en) | 2015-06-24 |
Family
ID=53445863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510069755.1A Pending CN104721052A (en) | 2015-02-10 | 2015-02-10 | Nanometer drug preparation device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104721052A (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10024154A1 (en) * | 2000-05-19 | 2001-11-22 | Inotech Encapsulation Ag Dotti | Encapsulation of cells/substances uses an injection pump to form small spherical particles in an immobilizing mixture with external vibration on the pump and an electrical field at the hardening vessel |
CN1531418A (en) * | 2001-03-22 | 2004-09-22 | ���ض������о�Ժ | Manufacturing dissolvable dosage forms |
CN1830536A (en) * | 2000-05-16 | 2006-09-13 | 明尼苏达大学评议会 | Produces high-volume pellets with multi-nozzle jetting |
US20070065372A1 (en) * | 2003-02-21 | 2007-03-22 | Robert Price | Process for the production of particles |
CN201052459Y (en) * | 2006-08-17 | 2008-04-30 | 温州医学院 | High-efficiency multi-needle electrostatic microcapsule, microsphere production equipment |
CN201253350Y (en) * | 2008-09-25 | 2009-06-10 | 高月荣 | High-pressure electrostatic field medicine micro-capsules forming device |
CN201735389U (en) * | 2010-05-21 | 2011-02-09 | 北京殷华激光快速成形与模具技术有限公司 | New device for microcapsule forming and high-pressure static electric field generating device |
CN101972038A (en) * | 2010-10-28 | 2011-02-16 | 上海理工大学 | Slowly-released filter stick essence microcapsule and preparation method thereof |
CN102350280A (en) * | 2011-06-23 | 2012-02-15 | 中国人民解放军第三○九医院 | Electrostatic drop generating device with ultrasonic vibration apparatus and method for preparing drug loaded gel microballoon using the same |
WO2012046898A1 (en) * | 2010-10-08 | 2012-04-12 | 주식회사 펨빅스 | Solid state powder coating device |
US20140263694A1 (en) * | 2013-03-15 | 2014-09-18 | Horn Bon Lin | Electrosprayer for arthropod tagging |
-
2015
- 2015-02-10 CN CN201510069755.1A patent/CN104721052A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830536A (en) * | 2000-05-16 | 2006-09-13 | 明尼苏达大学评议会 | Produces high-volume pellets with multi-nozzle jetting |
DE10024154A1 (en) * | 2000-05-19 | 2001-11-22 | Inotech Encapsulation Ag Dotti | Encapsulation of cells/substances uses an injection pump to form small spherical particles in an immobilizing mixture with external vibration on the pump and an electrical field at the hardening vessel |
CN1531418A (en) * | 2001-03-22 | 2004-09-22 | ���ض������о�Ժ | Manufacturing dissolvable dosage forms |
US20070065372A1 (en) * | 2003-02-21 | 2007-03-22 | Robert Price | Process for the production of particles |
CN201052459Y (en) * | 2006-08-17 | 2008-04-30 | 温州医学院 | High-efficiency multi-needle electrostatic microcapsule, microsphere production equipment |
CN201253350Y (en) * | 2008-09-25 | 2009-06-10 | 高月荣 | High-pressure electrostatic field medicine micro-capsules forming device |
CN201735389U (en) * | 2010-05-21 | 2011-02-09 | 北京殷华激光快速成形与模具技术有限公司 | New device for microcapsule forming and high-pressure static electric field generating device |
WO2012046898A1 (en) * | 2010-10-08 | 2012-04-12 | 주식회사 펨빅스 | Solid state powder coating device |
CN101972038A (en) * | 2010-10-28 | 2011-02-16 | 上海理工大学 | Slowly-released filter stick essence microcapsule and preparation method thereof |
CN102350280A (en) * | 2011-06-23 | 2012-02-15 | 中国人民解放军第三○九医院 | Electrostatic drop generating device with ultrasonic vibration apparatus and method for preparing drug loaded gel microballoon using the same |
US20140263694A1 (en) * | 2013-03-15 | 2014-09-18 | Horn Bon Lin | Electrosprayer for arthropod tagging |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Battaglia et al. | Techniques for the preparation of solid lipid nano and microparticles | |
Li et al. | Nanoparticles by spray drying using innovative new technology: The Büchi Nano Spray Dryer B-90 | |
CN104001437B (en) | Pickering emulsion with uniform particle size, and preparation method and application thereof | |
Liu et al. | Preparation of uniform-sized multiple emulsions and micro/nano particulates for drug delivery by membrane emulsification | |
Zhang et al. | Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application | |
US6998051B2 (en) | Particles from supercritical fluid extraction of emulsion | |
Xu et al. | Preparation of particle-stabilized oil-in-water emulsions with the microchannel emulsification method | |
CN103394314B (en) | A kind of preparation method of microcapsules of polyurethane parcel essential oil | |
Li et al. | Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation | |
Reverchon et al. | Supercritical fluids based techniques to process pharmaceutical products difficult to micronize: Palmitoylethanolamide | |
Jin et al. | Preparation of hydroxypropyl methyl cellulose phthalate nanoparticles with mixed solvent using supercritical antisolvent process and its application in co-precipitation of insulin | |
Xia et al. | Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals | |
Della Porta et al. | Monodisperse biopolymer nanoparticles by continuous supercritical emulsion extraction | |
Priamo et al. | Micronization processes by supercritical fluid technologies: a short review on process design (2008-2012) | |
CN106265542A (en) | A kind of preparation method of doxorubicin nanometer medicament granule | |
Chen et al. | Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process | |
He et al. | Robust pH-switchable pickering emulsions stabilized solely by organic Rosin-based particles with adjustable wettability | |
CN104151841B (en) | A kind of multilayer hollow casein base submicron composite micro-capsule and preparation method thereof | |
Shah | Use of nanotechnologies for drug delivery | |
CN113773521B (en) | Method for preparing emulsion and polymer particles with size less than 10 nanometers based on droplet self-breaking phenomenon | |
Melzig et al. | Formation of long-term stable amorphous ibuprofen nanoparticles via antisolvent melt precipitation (AMP) | |
Ao et al. | Colloidosomes formation by controlling the solvent extraction from particle-stabilized emulsions | |
Campardelli et al. | Palmitoylethanolamide sub-micronization using fast precipitation followed by supercritical fluids extraction | |
Xu et al. | Generation of polymer nanocapsules via a membrane-extrusion emulsification approach | |
CN104721052A (en) | Nanometer drug preparation device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150624 |
|
RJ01 | Rejection of invention patent application after publication |